FdaApplication
ANDA 208851
Identifiers
- fda_app_no: ANDA208851
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-09-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUDESONIDE | BUDESONIDE | 9MG | TABLET, EXTENDED RELEASE;ORAL |
1 product